Table 3.
Estimate | Std. Error | CI (95%) | Statistic | P-value | |
---|---|---|---|---|---|
| |||||
Assessment, Group type | |||||
Intercept | 0.740 | 0.556 | [−0.351, 1.831] | 1.331 | 0.184 |
Assessment | −0.034 | 0.082 | [−0.195, 0.126] | −0.422 | 0.673 |
pMCI group | 3.918 | 0.659 | [2.625. 5.212] | 5.950 | <0.001 |
Assessment * pMCI group | 0.372 | 0.095 | [0.186, 0.558] | 3.930 | <0.001 |
Assessment, Group type, Sex | |||||
Intercept | 0.815 | 0.969 | [−1.088, 2.719] | 0.841 | 0.401 |
Assessment time | −0.037 | 0.125 | [−0.282, 0.208] | −0.299 | 0.765 |
pMCI group | 4.053 | 1.126 | [1.842, 6.265] | 3.599 | <0.001 |
Males | −0.108 | 1.190 | [−2.445, 2.229] | −0.091 | 0.928 |
Assessment * pMCI group | 0.607 | 0.143 | [0.327, 0.888] | 4.254 | <0.001 |
Assessment * Males | −0.000 | 0.158 | [−0.310, 0.310] | −0.001 | 1.000 |
pMCI diagnosis * Males | −0.212 | 1.398 | [−2.957, 2.533] | −0.152 | 0.879 |
Assessment * pMCI group * Males | −0.397 | 0.182 | [−0.754, −0.040] | −2.186 | 0.029 |
Assessment, Group type, APOEε4 | |||||
Intercept | 0.585 | 0.576 | [−0.546, 1.716] | 1.015 | 0.310 |
Assessment | −0.010 | 0.093 | [−0.193, 0.173] | −0.109 | 0.913 |
pMCI group | 3.612 | 0.717 | [2.203, 5.020] | 5.036 | <0.001 |
APOEε4 carrier | 0.672 | 0.651 | [−0.607, 1.950] | 1.032 | 0.303 |
Assessment * pMCI group | 0.136 | 0.119 | [−0.098, 0.371] | 1.142 | 0.254 |
Assessment * APOEε4 carrier | −0.092 | 0.182 | [−0.449, 0.264] | −0.509 | 0.611 |
Assessment * pMCI group * APOEε4 carrier | 0.435 | 0.205 | [0.033, 0.837] | 2.123 | 0.034 |